Anlon Healthcare Complete Financial Statements
AHCL • Review detailed financials to uncover trends, confirm thesis & journal trades
5 Years of Data
2025 - 2021
Complete Financial Data Export
Export complete financial statements for Anlon Healthcare (AHCL).
Downloads include all available records across all periods.
For market performance, see the
AHCL stock price today
.
Profitability Ratios
Net Profit Margin
17.36%
2025 data
EBITDA Margin
26.45%
2025 data
Operating Margin
27.00%
2025 data
Return on Assets
11.60%
2025 data
Return on Equity
26.25%
2025 data
Balance Sheet Ratios
Current Ratio
3.88
2025 data
Debt to Equity
2.26
2025 data
Equity Ratio
44.20%
2025 data
Asset Turnover
0.67
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+22.3%
Year-over-Year
Net Profit Growth
-4.8%
Year-over-Year
EBITDA Growth
+9.4%
Year-over-Year
Expense Growth
+28.4%
Year-over-Year
Assets Growth
+41.4%
Year-over-Year
Equity Growth
+281.0%
Year-over-Year
Liabilities Growth
+41.4%
Year-over-Year
Operating Cash Flow Growth
-666.7%
Year-over-Year
Investing Cash Flow Growth
+200.0%
Year-over-Year
Financing Cash Flow Growth
+137.5%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Revenue | 148 | 121 | 67 | 113 | 58 | 16 |
| Expenses | 113 | 88 | 51 | 101 | 52 | 21 |
| EBITDA | 35 | 32 | 16 | 13 | 6 | -5 |
| Operating Profit Margin % | 24.00% | 27.00% | 23.00% | 11.00% | 9.00% | -33.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 4 | 4 | 4 | 4 | 4 | 3 |
| Profit Before Tax | 29 | 27 | 10 | 7 | 0 | -10 |
| Tax | 9 | 6 | 0 | 1 | 0 | 0 |
| Net Profit | 20 | 21 | 10 | 6 | 0 | -10 |
| Earnings Per Share (₹) | 6.40 | 6.37 | 6.68 | 4.85 | -0.09 | -8.53 |
Related Pages for Anlon Healthcare
Additional stock information and data for AHCL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 181 | 128 | 112 | 85 | 71 |
| Current Assets | 159 | 101 | 86 | 58 | 40 |
| Fixed Assets | 23 | 27 | 26 | 27 | 29 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 1 | 4 | 2 | 0 |
| Other Assets | 158 | 100 | 82 | 56 | 43 |
| LIABILITIES | |||||
| Total Liabilities | 181 | 128 | 112 | 85 | 71 |
| Current Liabilities | 41 | 57 | 61 | 55 | 38 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 80 | 21 | 7 | 2 | 2 |
| Share Capital | 40 | 16 | 12 | 12 | 12 |
| Reserves & Surplus | 41 | 5 | -5 | -10 | -10 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | -23 | -3 | -3 | -2 | -15 |
| Investing Activities | 3 | -3 | 0 | 0 | -3 |
| Financing Activities | 19 | 8 | 2 | 3 | 16 |
| Net Cash Flow | -1 | 2 | -1 | 1 | -2 |